Basit öğe kaydını göster

dc.contributor.authorTurhan, Nesrin
dc.contributor.authorSonsuz, Abdullah
dc.contributor.authorBAŞARANOĞLU, GÖKÇEN
dc.contributor.authorBasaranoglu, Metin
dc.date.accessioned2021-03-03T20:33:29Z
dc.date.available2021-03-03T20:33:29Z
dc.date.issued2011
dc.identifier.citationBasaranoglu M., Turhan N., Sonsuz A., BAŞARANOĞLU G., "Mallory-Denk Bodies in chronic hepatitis", WORLD JOURNAL OF GASTROENTEROLOGY, cilt.17, sa.17, ss.2172-2177, 2011
dc.identifier.issn1007-9327
dc.identifier.otherav_5a8405e3-6b7b-4404-a50f-1af12e13c9fc
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/63610
dc.identifier.urihttps://doi.org/10.3748/wjg.v17.i17.2172
dc.description.abstractMallory-Denk Bodies (MDB) are important as investigators, suggesting MDB as an indicator of the histologic severity of chronic hepatitis, causes of which include hepatitis C, primary biliary cirrhosis (PBC), and nonalcoholic fatty liver disease (NAFLD). Matteoni et al scored MDB in patients with NAFLD as none, rare and many, and reported that MDB plays a prominent role in this classification scheme in an earlier classification system. In this study, we evaluated 258 patients with chronic hepatitis due to metabolic, autoimmune and viral etiologies. Liver biopsy samples were evaluated with hematoxylin and eosin, periodic acid-Schiff-diastase, Gordon and Sweet's reticulin, Masson's trichrome, and iron stains. Both staging and grading were performed. Additionally, MDB were evaluated and discussed for each disease. We examined patients with nonalcoholic steatohepatitis (NASH; 50 patients), alcoholic hepatitis (10 patients), PBC (50 patients), Wilson disease (WD; 20 patients), hepatitis B (50 patients), hepatitis C (50 patients) and hepatocellular carcinoma (HCC; 30 patients). Frequency of MDB was as follows; NASH: 10 patients with mild in 60% and moderate in 40% and observed in every stage of the disease and frequently seen in zone 3. PBC: 11 patients with mild in 10%, moderate in 70%, and cirrhosis in 20%, and frequently seen in zone 1. WD: 16 patients with moderate and severe in 60% and cirrhosis in 40% and frequently seen in zone 1. Hep B: 3 patients with mild in 66% and severe in 34%. Hep C: 7 patients with mild in 40% and moderate in 60% and observed in every stage. HCC: 3 patients with hep B in 2 patients. We found that there is no relationship between MDB and any form of chronic hepatitis regarding histologic severity such as alcoholic steatohepatitis and NAFLD and variable zone distribution by etiology. (C) 2011 Baishideng. All rights reserved.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleMallory-Denk Bodies in chronic hepatitis
dc.typeMakale
dc.relation.journalWORLD JOURNAL OF GASTROENTEROLOGY
dc.contributor.departmentTurkey Specialized Higher Education & Research Hospital , ,
dc.identifier.volume17
dc.identifier.issue17
dc.identifier.startpage2172
dc.identifier.endpage2177
dc.contributor.firstauthorID200383


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster